Joseph A. Madri is Director at ALEXION PHARMACEUTICALS INC (ALXN). They have made 11 open-market trades across 1 company since 2007, most recently 2014-03-11.
CIK 0001231947
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXN | 239,217 | $43.7M |
Shares reported on the most recent Form 4, priced at the 2014-03-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2014-03-11 | 2014-03-13 | $178.61 | $10.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-02-07 | 2014-02-10 | $159.00 | $4.8M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · 10b5-1 | 2013-09-16 | 2013-09-18 | $115.00 | $3.5M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-08-03 | 2012-08-07 | $107.32 | $3.2M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-02-28 | 2012-03-01 | $84.02 | $1.3M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-07-27 | 2011-07-28 | $56.53 | $1.7M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-02-17 | 2011-02-22 | $92.83 | $1.8M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2010-10-29 | 2010-11-02 | $68.41 | $1.0M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2010-06-14 | 2010-06-16 | $52.87 | $1.1M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2010-02-16 | 2010-02-18 | $46.38 | $325K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2008-10-29 | 2008-10-30 | $38.23 | $153K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2007-08-21 | 2007-08-24 | $58.98 | $29K | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.